Sign in

CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870419387
Phone
310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Open-market buy Chairman and CEO bought 53,800 shares at $1.49 ($80,162)
  2. 4 Open-market buy Vice Chairman & COO bought 21,100 shares at an average $1.49 ($31,463)
  3. 4 Open-market buy Chairman and CEO bought 16,500 shares at an average $1.42 ($23,485)
  4. 4 Open-market buy Chairman and CEO bought 19,300 shares at an average $1.44 ($27,777)
  5. 4 Open-market buy Chairman and CEO bought 7,500 shares at an average $1.44 ($10,765)
  6. SC 13D/A Stake Beneficial Ownership Report
  7. 4 Open-market buy Chairman and CEO bought 12,000 shares at $1.45 ($17,400)
  8. 4 Open-market buy Chairman and CEO bought 30,500 shares at an average $1.46 ($44,385)
  9. 4 Open-market buy Chairman and CEO bought 8,500 shares at an average $1.48 ($12,560)
  10. 4 Open-market buy Chairman and CEO bought 13,250 shares at an average $1.42 ($18,760)
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 4 Open-market buy Director bought 10,000 shares at $1.58 ($15,800)
  14. 4 Open-market buy Vice Chairman & COO bought 1,700 shares at an average $1.55 ($2,628)
  15. 4 Open-market buy Chairman and CEO bought 17,500 shares at an average $1.57 ($27,507)
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Chairman and CEO bought 7,700 shares at an average $1.48 ($11,426)
  19. 4 Open-market buy Chairman and CEO bought 10,650 shares at an average $1.50 ($15,929)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 63 · 1,250 filings